Michael Caulfield Selected Research

Michael Caulfield Research Topics

2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2019
2	Myocardial Infarction 01/2018 - 01/2017
1	Inflammation (Inflammations) 01/2019
1	Thrombocytopenia (Thrombopenia) 10/2013
1	Anthrax 01/2012
1	Growth Disorders 01/2012
1	Malaria 11/2006
1	Insulin Resistance 03/2002
1	Type 2 Diabetes Mellitus (MODY) 03/2002
1	Weight Gain 01/2002

3	LipidsIBA 01/2019 - 03/2002
2	C-Reactive ProteinIBA 01/2019 - 03/2002
2	AntibodiesIBA 10/2013 - 01/2012
2	Insulin (Novolin)FDA Link 01/2012 - 03/2002
2	Troglitazone (Rezulin)FDA Link 03/2002 - 01/2002
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	Group II Phospholipases A2IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Platelet Membrane GlycoproteinsIBA 10/2013
1	Amiodarone (Amiodarona)FDA LinkGeneric 10/2013
1	Pharmaceutical PreparationsIBA 10/2013
1	Integrin alpha2IBA 10/2013
1	Conjugate VaccinesIBA 01/2012
1	Capsules (Microcapsules)IBA 01/2012
1	AntigensIBA 01/2012
1	VaccinesIBA 01/2012
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2012
1	Protein Subunit VaccinesIBA 11/2006
1	Metformin (Glucophage)FDA LinkGeneric 03/2002
1	Fibrinogen (Factor I)FDA Link 03/2002
1	Glyburide (Glibenclamide)FDA LinkGeneric 03/2002
1	Glucose (Dextrose)FDA LinkGeneric 03/2002
1	oxidized low density lipoproteinIBA 03/2002
1	Plasminogen Activator Inhibitor 1IBA 03/2002
1	LeptinIBA 01/2002